also known potent selective nociceptin receptor antagonist development blackthorn therapeutics eli lilly treatment major depressive disorder demonstrated proofofconcept clinical efficacy phase ii clinical trials treatment also investigation treatment alcoholism similarly reached phase ii clinical studies indication development drug article relating nervous system stub help wikipedia expanding